Cbl-b-IN-12
Cbl-b-IN-12 (Example 10) is a casitas B-lineage lymphoma-b (CBL-B) inhibitor with an IC50 of [1].
Product Specifications
CAS Number
[2851871-29-7]
UNSPSC
12352005
Target
E1/E2/E3 Enzyme
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cbl-b-in-12.html
Solubility
10 mM in DMSO
Smiles
O=C1N(C2=CC=CC(C3(CC4=NN=CN4C)COC3)=C2)C=C5C(C(F)(F)F)=CC(CN6CCC7(CC7)C6)=CN15
Molecular Formula
C28H29F3N6O2
Molecular Weight
538.56
References & Citations
[1]Yingzhi Bi, et al. Compounds, compositions and methods of treating cancer. Patent WO2022221704A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
040998-ML490 100 µL
RGMA, CT (RGMA, RGM, Repulsive guidance molecule A, RGM domain family member A) (MaxLight 490) discontinued
Ask
View Details 
